Synonyms: compound 32 [PMID: 38552030] | compound 88 [WO2019238424A1] | GLPG-3970
Compound class:
Synthetic organic
Comment: GLPG3970's chemical structure was revealed during the first disclosures session at the 2022 ACS meeting in Chicago. This is Galapagos' oral, salt inducible kinase 2 and 3 (SIK2/3) inhibitor that was proposed for treating inflammatory diseases. The discovery of GLPG3970 was reported in March 2024 [2]. Selectively inhibiting SIK2/3 is proposed to reduce SIK1-related cardiovascular side effects.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Classification | |
Compound class | Synthetic organic |
IUPAC Name |
8-methoxy-6-[7-(2-morpholin-4-ylethoxy)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one |
Synonyms |
compound 32 [PMID: 38552030] | compound 88 [WO2019238424A1] | GLPG-3970 |
Database Links | |
CAS Registry No. | 2403733-82-2 (source: PubChem) |
ChEMBL Ligand | CHEMBL4802154 |
GtoPdb PubChem SID | 472319279 |
PubChem CID | 146273261 |
Search Google for chemical match using the InChIKey | XASOHFCUIQARJT-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | XASOHFCUIQARJT |
UniChem Compound Search for chemical match using the InChIKey | XASOHFCUIQARJT-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | XASOHFCUIQARJT-UHFFFAOYSA-N |